Literature DB >> 31202607

Lectins modulate the functional properties of GluN1/GluN3-containing NMDA receptors.

Katarina Hemelikova1, Marharyta Kolcheva2, Kristyna Skrenkova1, Martina Kaniakova1, Martin Horak3.   

Abstract

N-methyl-d-aspartate receptors (NMDARs) play an essential role in excitatory neurotransmission within the mammalian central nervous system (CNS). NMDARs are heteromultimers containing GluN1, GluN2, and/or GluN3 subunits, thus giving rise to a wide variety of subunit combinations, each with unique functional and pharmacological properties. Importantly, GluN1/GluN3A and GluN1/GluN3B receptors form glycine-gated receptors. Here, we combined electrophysiology with rapid solution exchange in order to determine whether the presence of specific N-glycans and/or interactions with specific lectins regulates the functional properties of GluN1/GluN3A and GluN1/GluN3B receptors expressed in human embryonic kidney 293 (HEK293) cells. We found that removing putative N-glycosylation sites alters the functional properties of GluN1/GluN3B receptors, but has no effect on GluN1/GluN3A receptors. Moreover, we found that the functional properties of both GluN1/GluN3A and GluN1/GluN3B receptors are modulated by a variety of lectins, including Concanavalin A (ConA), Wheat Germ Agglutinin (WGA), and Aleuria Aurantia Lectin (AAL), and this effect is likely mediated by a reduction in GluN1 subunit-mediated desensitization. We also found that AAL has the most profound effect on GluN1/GluN3 receptors, and this effect is mediated partly by a single N-glycosylation site on the GluN3 subunit (specifically, N565 on GluN3A and N465 on GluN3B). Finally, we found that lectins mediate their effect only when applied to non-activated receptors and have no effect when applied in the continuous presence of glycine. These findings provide further evidence to distinguish GluN1/GluN3 receptors from the canonical GluN1/GluN2 receptors and offer insight into how GluN1/GluN3 receptors may be regulated in the mammalian CNS.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Desensitization; Glutamate receptor; Glycosylation; Ion channel; Patch-clamp technique; Posttranslational modification

Mesh:

Substances:

Year:  2019        PMID: 31202607     DOI: 10.1016/j.neuropharm.2019.107671

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  3 in total

Review 1.  Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.

Authors:  Kasper B Hansen; Lonnie P Wollmuth; Derek Bowie; Hiro Furukawa; Frank S Menniti; Alexander I Sobolevsky; Geoffrey T Swanson; Sharon A Swanger; Ingo H Greger; Terunaga Nakagawa; Chris J McBain; Vasanthi Jayaraman; Chian-Ming Low; Mark L Dell'Acqua; Jeffrey S Diamond; Chad R Camp; Riley E Perszyk; Hongjie Yuan; Stephen F Traynelis
Journal:  Pharmacol Rev       Date:  2021-10       Impact factor: 18.923

2.  Pursuing the Complexity of Alzheimer's Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and N-Methyl-d-Aspartate Receptor Antagonists.

Authors:  Jan Konecny; Anna Misiachna; Martina Hrabinova; Lenka Pulkrabkova; Marketa Benkova; Lukas Prchal; Tomas Kucera; Tereza Kobrlova; Vladimir Finger; Marharyta Kolcheva; Stepan Kortus; Daniel Jun; Marian Valko; Martin Horak; Ondrej Soukup; Jan Korabecny
Journal:  Biomolecules       Date:  2020-12-22

3.  The pathogenic S688Y mutation in the ligand-binding domain of the GluN1 subunit regulates the properties of NMDA receptors.

Authors:  Kristyna Skrenkova; Jae-Man Song; Stepan Kortus; Marharyta Kolcheva; Jakub Netolicky; Katarina Hemelikova; Martina Kaniakova; Barbora Hrcka Krausova; Tomas Kucera; Jan Korabecny; Young Ho Suh; Martin Horak
Journal:  Sci Rep       Date:  2020-10-29       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.